These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 6816774)

  • 21. [Immunity during ampicillin administration against a background of immunosuppression].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1998; 61(6):39-41. PubMed ID: 9929815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anticancer drugs on the immune system in humans.
    Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immunobiological properties of trimezon and levamisole on models of humoral and cell-mediated immunogenesis].
    Liubin GS; Kuz'mitskiĭ BB
    Eksp Klin Farmakol; 1997; 60(1):50-2. PubMed ID: 9162286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotoxicology--1985.
    Loose LD
    Year Immunol; 1986; 2():365-70. PubMed ID: 3107240
    [No Abstract]   [Full Text] [Related]  

  • 25. Possibilities of stimulating the immune system.
    Gergely J
    Ther Hung; 1982; 30(1):5-13. PubMed ID: 6765329
    [No Abstract]   [Full Text] [Related]  

  • 26. CTLA4Ig: effects on cellular and humoral immunity and macrophage activation.
    Schaub M; Stadlbauer TH; Sayegh MH
    Exp Nephrol; 1997; 5(5):370-4. PubMed ID: 9386972
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of anti-rheumatic drugs on immunological parameters.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():109-13. PubMed ID: 365156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of humoral immunity to protein antigen without adjuvant in rats exposed to immunosuppressive chemicals.
    Koller LD; Exon JH; Norbury KC
    J Toxicol Environ Health; 1983; 12(2-3):173-81. PubMed ID: 6655728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression by chemical agents.
    Bach JF
    Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894
    [No Abstract]   [Full Text] [Related]  

  • 30. [Perspectives of immunopharmacology].
    de Weck AL
    Schweiz Rundsch Med Prax; 1985 Feb; 74(6):107-9. PubMed ID: 3975521
    [No Abstract]   [Full Text] [Related]  

  • 31. Mode of action of immunological adjuvants.
    Allison AC
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):619-30. PubMed ID: 392086
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological effects of diethylstilbestrol and estramustine phosphate.
    Haukaas SA
    Scand J Urol Nephrol Suppl; 1984; 83():1-32. PubMed ID: 6387896
    [No Abstract]   [Full Text] [Related]  

  • 33. [An approach to immune suppression: control of the immune response (author's transl)].
    Ramos A; Hoecker G
    Rev Med Chil; 1978 Apr; 106(4):296-302. PubMed ID: 663473
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of immunologic alterations caused by halogenated aromatic hydrocarbons.
    Luster MI; Faith RE
    Ann N Y Acad Sci; 1979 May; 320():572-8. PubMed ID: 313178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
    Shanurin SIu; Belevskaia RG; Mikhaĭlova AA; Shanurin MIu
    Eksp Klin Farmakol; 1995; 58(5):53-6. PubMed ID: 8704592
    [No Abstract]   [Full Text] [Related]  

  • 36. [Basis of immunosuppressive effect of D-penecillamine].
    Schumacher K
    Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide (author's transl)].
    Terashima M
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):495-9. PubMed ID: 6456215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor induced immunosuppression.
    Roth JA
    Surg Gynecol Obstet; 1983 Feb; 156(2):233-40. PubMed ID: 6186039
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunomodulation by cancer chemotherapeutic agents.
    Periti P; Mini E
    Chemioterapia; 1987 Dec; 6(6):399-402. PubMed ID: 3325174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of levamisole in nephrological practice (a review of the literature)].
    Drannik GN; Kolesnik NA
    Vrach Delo; 1982 May; (5):12-6. PubMed ID: 7051554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.